Waheed Jamal
Impact in
-
- Heart Failure Treatment and Management
- Cardiovascular Function and Risk Factors
- Cardiac Fibrosis and Remodeling
- Atrial Fibrillation Management and Outcomes
- Acute Myocardial Infarction Research
-
- Diabetes Treatment and Management
- Diabetes, Cardiovascular Risks, and Lipoproteins
Papers in
-
- Heart Failure Treatment and Management 21
- Atrial Fibrillation Management and Outcomes 1
-
- Diabetes Treatment and Management 9
- Co-authors
- Stefan D. Anker (17 shared papers)Martina Brueckmann (14 shared papers)Faiez M. Zannad (13 shared papers)Gerasimos S Filippatos (12 shared papers)Milton Packer (13 shared papers)Javed Butler (13 shared papers)Stuart Pocock (15 shared papers)João Pedro Ferreira (11 shared papers)
- Journals
- European Journal of Heart Failure (5 papers)European Heart Journal (4 papers)Journal of the American College of Cardiology (4 papers)New England Journal of Medicine (4 papers)Circulation (3 papers)
- Partner nations
- GermanyUnited StatesUnited Kingdom
In The Last Decade
Waheed Jamal
28 papers receiving 10.4k citations
Waheed Jamal's Hit Papers
Peers
Comparison fields: 5 of 99
- Cardiology and Cardiovascular Medicine 6.9k
- Endocrinology, Diabetes and Metabolism 4.3k
- Nephrology 891
- Internal Medicine 69
- Geriatrics and Gerontology 62
Countries citing papers authored by Waheed Jamal
This map shows the geographic impact of Waheed Jamal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Waheed Jamal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Waheed Jamal more than expected).
Fields of papers citing papers by Waheed Jamal
This network shows the impact of papers produced by Waheed Jamal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Waheed Jamal. The network helps show where Waheed Jamal may publish in the future.
Co-authors
The 25 scholars most cited alongside Waheed Jamal, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure Hit paper breakdown → | 2020 | 3829 |
| 2 | Empagliflozin in Heart Failure with a Preserved Ejection Fraction Hit paper breakdown → | 2021 | 3467 |
| 3 | SGLT2 inhibitors in patients with heart failure with reduced ejection fraction: a meta-analysis of the EMPEROR-Reduced and DAPA-HF trials Hit paper breakdown → | 2020 | 1022 |
| 4 | Effect of Empagliflozin on the Clinical Stability of Patients With Heart Failure and a Reduced Ejection Fraction Hit paper breakdown → | 2020 | 325 |
| 5 | Effect of Empagliflozin on Cardiovascular and Renal Outcomes in Patients With Heart Failure by Baseline Diabetes Status Hit paper breakdown → | 2020 | 274 |
| 6 | 2019 | 205 | |
| 7 | 2011 | 201 | |
| 8 | Empagliflozin after Acute Myocardial Infarction Hit paper breakdown → | 2024 | 188 |
| 9 | 2020 | 170 | |
| 10 | 2020 | 141 | |
| 11 | 2021 | 141 | |
| 12 | 2021 | 134 | |
| 13 | 2020 | 106 | |
| 14 | 2020 | 98 | |
| 15 | 2021 | 93 | |
| 16 | 2013 | 71 | |
| 17 | 2021 | 70 | |
| 18 | Effect of Empagliflozin on Heart Failure Outcomes After Acute Myocardial Infarction: Insights From the EMPACT-MI Trial Hit paper breakdown → | 2024 | 66 |
| 19 | 2020 | 57 | |
| 20 | 2019 | 41 |
About Waheed Jamal
Waheed Jamal is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism, Nephrology, Internal Medicine and Genetics, having authored 29 papers that have together received 10.8k indexed citations. Recurring topics across this work include Heart Failure Treatment and Management (21 papers), Diabetes Treatment and Management (9 papers), Virus-based gene therapy research (2 papers), Chronic Kidney Disease and Diabetes (2 papers), RNA Interference and Gene Delivery (1 paper), Venous Thromboembolism Diagnosis and Management (1 paper), Atrial Fibrillation Management and Outcomes (1 paper) and Photodynamic Therapy Research Studies (1 paper). The work is most often cited by research in Cardiology and Cardiovascular Medicine (6.9k citations), Endocrinology, Diabetes and Metabolism (4.3k citations), Nephrology (891 citations), Internal Medicine (69 citations) and Geriatrics and Gerontology (62 citations). Waheed Jamal has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include Stefan D. Anker, Martina Brueckmann, Faiez M. Zannad, Gerasimos S Filippatos, Milton Packer, Javed Butler, Stuart Pocock, João Pedro Ferreira, Anne Pernille Ofstad and Egon Pfarr. Their work appears in journals such as European Journal of Heart Failure, European Heart Journal, Journal of the American College of Cardiology, New England Journal of Medicine and Circulation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.